HomeAboutContactTissueSupportResearchJoin
News

Tibotec Pharmaceuticals Seeks European Marketing Authorization For Investigational Once-Daily HIV Treatment TMC278


Gilead Sciences Submits European Marketing Application For Once-Daily Single-Tablet Regimen Of TruvadaŽ And TMC278 For The Treatment Of HIV Infect


AVAC Calls For Speedy Funding Of Critical Microbicide Follow-Up Studies


A Scientific Breakthrough On How HIV Takes Control Of Cell Division


Commitments To Global HIV/AIDS Programs Falter For 'First Time In 15 Years,' UNAIDS Chief Says

 

Support

What to do...

If you should need any kind of assistance please do not hesitate to contact us. We will respond imediately to make sure your questions are answered in a timely fashion.

Thank you for visiting NNAB

 
 
  © Copyright 2005 NNAB. All Rights Reserved.